Compare trial results at 24 months of two different minimally invasive glaucoma surgeries— the Hydrus™ and the iStent® without cataract surgery being performed at the same time.
Learn more about the iStent Supra® microdevice from Glaukos. This is a 4mm (less than one quarter inch long) tube with a hole at each end. Made of Polyethersulfone (PES) and titanium.
The iStent is the first FDA approved “trabecular microbypass device.” These devices aim to shunt aqueous fluid directly from the anterior chamber into Schlemm’s canal. Learn More about it
Iqbal Ike K. Ahmed, MD, FRCSC, asks a group of experts featuring Mark J. Gallardo, MD; Nathan M. Radcliffe, MD; Mahmoud A. Khaimi, MD; David Richardson, MD; and I. Paul Singh, MD, to address the misconceptions and barriers to adoption for ab interno canaloplasty (ABiC). The group explains how ABiC iTrack (Ellex) compares to other minimally invasive glaucoma surgery (MIGS) procedures.
At ASCRS 2018 in Washington, DC, a group of surgeons experienced in interventional glaucoma therapies sat down to discuss the roles of selective laser trabeculoplasty (SLT) and microinvasive glaucoma surgery (MIGS) for treatment of open angle glaucoma (OAG).
